---
title: "Maison Solutions holds annual shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293612608.md"
description: "Maison Solutions held its annual shareholder meeting on July 22, 2026. During the meeting, shareholders elected five new directors to the board and ratified Kreit & Chiu CPA LLP as the independent auditor for the fiscal year ending April 30, 2027."
datetime: "2026-07-23T12:04:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293612608.md)
  - [en](https://longbridge.com/en/news/293612608.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293612608.md)
generator: "portal-rs"
---

# Maison Solutions holds annual shareholder meeting

-   Maison Solutions held its annual shareholder meeting on July 22, 2026. \* Shareholders elected five directors to the board. \* Shareholders ratified Kreit & Chiu CPA LLP as independent auditor for the fiscal year ending April 30, 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maison Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-080636), on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MSS.US](https://longbridge.com/en/quote/MSS.US.md)

## Related News & Research

- [Maison Solutions receives Nasdaq notice over late annual filing, risks noncompliance with listing rules](https://longbridge.com/en/news/297017390.md)
- [Maison Solutions says all outstanding convertible notes are paid off](https://longbridge.com/en/news/297049848.md)
- [Damartex reports FY2025-26 annual results release available](https://longbridge.com/en/news/298344100.md)
- [BioLineRx outlines Phase 1/2a GLIX1 trial in recurrent high-grade glioma at EANO 2026](https://longbridge.com/en/news/298582374.md)
- [Mexedia notifies availability of press release](https://longbridge.com/en/news/298011253.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**